NEOSBACT NEW OINTMENT is a combination of Bacitracin, Neomycin, and Polymyxin B, which belongs to the group of medicines called Antibiotics. It is indicated for conditions such as prophylaxis in graft donor sites, the suturing of lacerations, accidental cuts, scratches, and abrasions, managing infected ulcers, accidental cuts, scratches, abrasions, and superficial skin infections following surgical procedures and minor burns, impetigo and secondarily infected skin conditions, managing susceptible bacterial infections of the eye and its adnexa, including conjunctivitis, keratitis, infected corneal ulcer, ulcerative blepharitis with associated conjunctivitis, and chronic dacryocystitis, used pre- and postoperatively to manage ocular infection following surgical procedures, including removal of foreign bodies from the eye.
Apply a thin layer of NEOSBACT NEW OINTMENT on the affected area after the removal of debris, pus, and crusts from the wound. Do not continue NEOSBACT NEW OINTMENT more than seven days without medical advice. NEOSBACT NEW OINTMENT is not recommended for use in patients allergic to antibiotics and nerve deafness. NEOSBACT NEW OINTMENT should be used with caution in patients with kidney disease.
NEOSBACT NEW OINTMENT is not recommended for use in pregnant and breastfeeding women. NEOSBACT NEW OINTMENT is not recommended for use in children below 2 years of age. The most common side effects are skin redness and dryness (application site reactions). Consult your doctor if any of the above side effects worsen or persist for a longer duration.
No content available
